Mugdha Chopra – Awinsa Life Sciences
View Detailed Executive Profile →Professional Overview
- Mugdha Chopra co-founded AWINSA Life Sciences in April 2018, assuming the role of Director, contributing significantly to the establishment and direction of the organization.
- Prior to joining AWINSA Life Sciences, Mugdha held the position of Associate Vice President for Pharmacovigilance and Clinical Safety at APCER Life Sciences from April 2017, showcasing leadership in safety protocols within the pharmaceutical sector.
- From July 2012 to April 2017, Mugdha served as Operations Lead at APCER Life Sciences, effectively managing operational initiatives and ensuring compliance in clinical practices.
- Mugdha's career began as a Senior Research Scientist at Ranbaxy from June 2008 to June 2012, where contributions to drug research and development were critical for advancing healthcare solutions.
- Previous to the tenure at Ranbaxy, Mugdha gained experience as a Dental Surgeon from June 2005, providing dental healthcare and patient management over multiple positions until April 2007.
- Mugdha worked at DAYANAND MEDICAL COLLEGE AND HOSPITAL as a Dental Surgeon from August 2004 to May 2005, fostering clinical skills in a hospital setting.
- Prior roles in dental practices from August 2002 to July 2004 highlighted a strong foundation in dental surgery, central to early career achievements.
- Throughout the career journey, challenges included transitioning from a clinical dentistry focus to pivotal roles in life sciences, demonstrating adaptability and a commitment to advancing healthcare sectors.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Ranbaxy | Senior Research Scientist | Jun 2008 – Jun 2012 |
| Dental Practice | Dental Surgeon | Jun 2005 – Apr 2007 |
| APCER Life Sciences | Operations Lead | Jul 2012 – Apr 2017 |
| DAYANAND MEDICAL COLLEGE AND HOSPITAL | Dental Surgeon | Aug 2004 – May 2005 |
| Dental Practice | Dental Surgeon | Aug 2002 – Jul 2004 |
| APCER Life Sciences | Associate Vice President-PV and Clinical Safety | Apr 2017 – Apr 2018 |
| AWINSA Life Sciences | Co-Founder and Director | Apr 2018 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Awinsa Life Sciences corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Mugdha Chopra's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Awinsa Life Sciences's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)